NeuroSearch and Janssen sign development deal
This article was originally published in Scrip
Executive Summary
NeuroSearch and Janssen Pharmaceutica have agreed to develop and commercialise jointly new treatments for various central nervous system diseases, based on the companies' joint expertise in neuroscience.